BDBM286178 3-(4-((5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)methoxy)bicyclo[2.2.1]heptan-1-yl)propanoic acid::US9518000, Example 71
SMILES: CC1(C)Cc2cc(Cl)cc(COC34CCC(CCC(O)=O)(CC3)C4)c2O1
InChI Key: InChIKey=IJYQINXYEJMYHR-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free fatty acid receptor 4 (Homo sapiens (Human)) | BDBM286178 (3-(4-((5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran...) | Reactome pathway KEGG GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.64E+3 | n/a | n/a | n/a | 25 |
Bristol-Myers Squibb Company US Patent | Assay Description The human and mouse GPR120-mediated intracellular phosphorylated ERK assays were established using CHOA12 cells stably transfected with the short for... | US Patent US9518000 (2016) BindingDB Entry DOI: 10.7270/Q2GH9M00 | |||||||||||
More data for this Ligand-Target Pair |